TY - JOUR
T1 - Embracing the complexity
T2 - Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology Position Paper
AU - Pergolotti, Mackenzi
AU - Battisti, Nicolò Matteo Luca
AU - Padgett, Lynne
AU - Sleight, Alix G
AU - Abdallah, Maya
AU - Newman, Robin
AU - Van Dyk, Kathleen
AU - Covington, Kelley R
AU - Williams, Grant R
AU - van den Bos, Frederiek
AU - Pollock, YaoYao
AU - Salerno, Elizabeth A
AU - Magnuson, Allison
AU - Gattás-Vernaglia, Isabella F
AU - Ahles, Tim A
N1 - Funding Information:
Dr. Pergolotti and Kelley Covington receive salary from ReVital Cancer Rehabilitation, Select Medical. Dr. Van Dyk reports grants from NIH/NCI, grants from American Cancer Society, grants from Breast Cancer Research Foundation, during the conduct of the study. Dr. Padgett has received consulting fees from Carevive Systems. Dr. Battisti reports personal fees from Genomic Health, personal fees from Pfizer, outside the submitted work. The remaining authors have no conflicts of interest to declare.
Publisher Copyright:
© 2019 Elsevier Inc.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/3
Y1 - 2020/3
N2 - Cancer-related cognitive decline (CRCD) may have particularly significant consequences for older adults, impacting their functional and physical abilities, level of independence, ability to make decisions, treatment adherence, overall quality of life, and ultimately survival. In honor of Dr. Hurria's work we explore and examine multiple types of screening, assessment and non-pharmacologic treatments for CRCD. We then suggest future research and clinical practice questions to holistically appreciate the complexity of older adults with cancer's experiences and fully integrate the team-based approach to best serve this population.
AB - Cancer-related cognitive decline (CRCD) may have particularly significant consequences for older adults, impacting their functional and physical abilities, level of independence, ability to make decisions, treatment adherence, overall quality of life, and ultimately survival. In honor of Dr. Hurria's work we explore and examine multiple types of screening, assessment and non-pharmacologic treatments for CRCD. We then suggest future research and clinical practice questions to holistically appreciate the complexity of older adults with cancer's experiences and fully integrate the team-based approach to best serve this population.
KW - Assessment
KW - Cancer-related cognitive decline
KW - Older adults
KW - Rehabilitation
UR - http://www.scopus.com/inward/record.url?scp=85073620464&partnerID=8YFLogxK
U2 - 10.1016/j.jgo.2019.09.002
DO - 10.1016/j.jgo.2019.09.002
M3 - Review article
C2 - 31619372
SN - 1879-4068
VL - 11
SP - 237
EP - 243
JO - Journal of geriatric oncology
JF - Journal of geriatric oncology
IS - 2
ER -